Literature DB >> 16361650

Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.

Joseph Meirion Thomas.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16361650     DOI: 10.1200/JCO.2005.04.0147

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Sentinel node biopsy confers no added protection to patients with melanoma.

Authors:  Spyros Retsas
Journal:  J R Soc Med       Date:  2007-08       Impact factor: 5.344

2.  Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.

Authors:  Friederike Egberts; A Momkvist; J H Egberts; K C Kaehler; M Weichenthal; A Hauschild
Journal:  Tumour Biol       Date:  2009-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.